DYN
Dyne Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$24.28
−2.69%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.93x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.04x
- Net debt / EBITDA
- 1.32x
Liquidity & coverage
- Current ratio
- 12.02x
- Quick ratio
- 12.02x
- Cash ratio
- 11.51x
- Interest coverage
- -36.05x
- EBITDA / interest
- -33.26x
- Working capital
- $859.9M
Cash & dividend
- FCF / debt
- -25.12x
- Cash flow / debt
- -24.05x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026